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Volume 58, Number 1 Abstracts 277women and 12 men), with a mean age of 32 years (range, 16-61 years),
underwent hypercoagulable testing. Some abnormality of coagulation was
discovered in 14 patients (25.5%), comprising 12 women and two men,
with a mean age of 27 years (range 16-46 years). A factor V Leiden mutation
was present in six patients, protein S deﬁciency in four, and a plasminogen-
activator inhibitor-1 deﬁciency in two. One patient each had protein C deﬁ-
ciency and anticardiolipin antibodies, factor V mutation, factor II mutation,
and antiphospholipid antibodies. Patients were initially treated with ﬁrst rib
recession and scalenectomy but not with venous reconstruction. At 2 weeks
postoperatively, patients were assessed by venography for possible venoplasty
of stenotic or occluded veins. In the 14 patients with hypercoagulability, 10
(71%), had stenotic or occluded veins. At 2 weeks, 32 of 41 patients (78%)
tested for hypercoagulability, but with negative ﬁndings, had stenotic or
occluded veins. Of the 82 patients not tested for hypercoagulability at 2
weeks, 53 (61%) had stenotic or occluded veins by duplex scan assessment.
Comment: The authors found some patients with abnormalities of
coagulation in their series. Their suggestion that hypercoagulability testing
be considered in some patients with axillosubclavian vein thrombosis there-
fore seems reasonable. The data here give us some idea of what one will ﬁnd
if one initiates hypercoagulability testing in selected patients with sponta-
neous axillary/subclavian vein thrombosis. The nature of the data and the
limited analysis possible from this sort of data makes this basically a “hypoth-
esis seeking” study. It does not really tell you what to do with that informa-
tion once you ﬁnd it or if the “hypercoagulability” was the primary inciting
problem, a contributing problem, or would not really be much of a problem
at all in the absence of compression of the vein!Statins Reduce Neurologic Injury in Asymptomatic Carotid
Endarterectomy Patients
Heyer EJ, Mergeche JL, Bruce SS, et al. Stroke 2013;44:1150-2.
Conclusion: Preoperative statin use is associated with less neurologic
injury after carotid endarterectomy (CEA) for asymptomatic stenosis.
Summary: There is considerable controversy about the current
therapeutic index of CEA for asymptomatic carotid stenosis. Given what
everyone agrees is a relatively narrow therapeutic index for CEA in the treat-
ment of patients with asymptomatic carotid stenosis, there is considerable
interest in adjunctive measures to potentially improve even further
outcomes of CEA for asymptomatic carotid stenosis. The Asymptomatic
Carotid Surgery Trial suggested a reduction in perioperative risk of stroke
and death from 6% to 2% for those on “lipid-lowering agents” (Halliday
A et al, Lancet 2010;376:1074-84). However, data on 1252 patients under-
going CEA for asymptomatic stenosis in Canada failed to demonstrate
a protective effect of statins (Kennedy J et al, Stroke 2005;36:2072-6). In
addition to stroke, effects of CEA and other carotid interventions on post-
operative cognitive dysfunction are also of interest. Potential effects of statins
on postoperative cognitive dysfunction have not been studied previously. In
this study, the authors sought to determine whether statins were neuropro-
tective in a cohort of asymptomatic CEA patients taking statin medications.
This study deﬁned neurologic injury after CEA as both clinical stroke and
signiﬁcant cognitive dysfunction. Agreeing to participate in the study were
328 asymptomatic patients with carotid stenosis scheduled for elective
CEA. Patients were evaluated for perioperative stroke and cognitive dysfunc-
tion. Cognitive dysfunction was determined by a battery of neuropsychomet-
ric tests performed preoperatively and 1 day postoperatively (Heyer EJ et al,
ArchNeurol 2002;59:217-22). Patients taking a statinmedication at the time
of their CEA had a lower incidence of clinical stroke (0.0% vs 3.1%; P ¼ .02)
and a lower incidence of cognitive dysfunction (11% vs 20.0%; P ¼ .03).
Application of a multiple variant regression model indicated statin use was
signiﬁcantly associated with decreased odds of cognitive dysfunction (odds
ratio, 0.51; 95% conﬁdence interval, 0.27-0.96; P ¼ .04).
Comment: Previous studies have suggested that postoperative cogni-
tive dysfunction can predict disability and perhaps even early death (Stein-
metz J et al, Anesthesiology 2009;110:548-55). Therefore, although this
was a single-center study and such things as reasons for statin medication
and duration of statin medication, as well as dosages of statin medications,
were not controlled, the data are intriguing enough that more formal eval-
uation on the effects of statin medications in preserving cognitive function
in CEA patients, while controlling for the obvious variables of dosage, dura-
tion and type of statin medication, would seem worthwhile.Nationwide Outcomes of Surgical Embolectomy for Acute Pulmonary
Embolism
Kilic A, Shah AS, Conte JV, et al. J Thorac Cardiovasc Surg 2013;145:373-7.
Conclusion: There is a nationwide inpatient mortality rate of 27.2%
after pulmonary embolectomy. Death after pulmonary embolectomy is
affected by factors other than arena of care.Summary: Acute pulmonary embolism (PE) causesw300,000 deaths
each year in the United Sates (Heit JA et al, US Blood 2005;106:267a).
Surgical pulmonary embolectomy is an option for patients with severe PE
and contraindications to thrombolysis or who have persistent hypotension
after initial therapy. Previous outcomes reported for surgical pulmonary
embolectomy have generally been limited to small patient cohorts. In the
present study, the authors evaluated nationwide outcomes of surgical embo-
lectomy for acute PE. The authors studied adult patients undergoing
surgical embolectomy for acute PE from 1999 to 2008. Patients were iden-
tiﬁed in the weighted Nationwide Inpatient Sample. The primary end point
was in-patient mortality. Multivariate logistic regression analysis was con-
ducted to identify independent predictors for patient mortality. During
the study period, 2709 eligible patients were identiﬁed as undergoing
surgical embolectomy for acute PE. Mean age was 57.0 6 16.0 years,
and 1242 (48.8%) were women. Before surgical embolectomy, 10.3% of
the patients had undergone thrombolysis. Overall inpatient mortality was
27.2%. By multivariate analysis, increased Charlson Comorbidity Index
(odds ratio, 1.37; 95% conﬁdence interval, 1.12-1.69; P ¼ .003) increased
the odds of inpatient death. Black patients were more than twofold more
likely to die during hospitalization than white patients (odds ratio, 2.29;
95% conﬁdence interval, 1.18-4.46; P ¼ .02). Univariate analysis found
age, payment type, hospital location (urban vs rural), hospital embolectomy
volume, and surgical embolectomy volume were associated with in-patient
mortality (each P < .2). None of these factors, however, correlated with
mortality in the multivariate model.
Comment: Many variables that one would expect to be associated with
increased mortality for an operation with high mortality were, in fact, found
not to inﬂuence the mortality of surgical embolectomy for acute PE. This
likely relates to the fact that no surgeon or hospital has a large volume of expe-
rience with this particular procedure. There were in fact only 2.3 cases per-
formed each year in hospitals that performed the procedure. This is likely
too few cases for pathways of care, surgical expertise, and anesthesia
expertise to generate an effect. The authors suggest that it may be for prudent
for centers with qualiﬁed surgeons to avoid delays in treatment rather than
transfer care because of a perception of improved outcomes. However, the
oppositemay also be true, in that development of a regional center for surgical
pulmonary embolectomy may allow acquisition of sufﬁcient number of cases
in a single center to actually improve outcomes of this procedure.Surgical Never Events in the United States
Mehtsun WT, Ibrahim AM, Diener-West M, et al. Surgery 2013;153:465-
72.
Conclusion: Patient and provider characteristics may help guide
prevention strategies for surgical “never events.”
Summary: Surgical “never events” include retained foreign body,
wrong site surgery, wrong patient surgery, and wrong procedure operations.
Despite agreement that these are always avoidable, they persist within real-
world surgical practice. “Never events” clearly can be catastrophic for a patient
but also destructive to a surgeon’s career and a hospital’s reputation. They
may be a surrogate marker for unsafe hospital systems and a poor safety
culture (Reason J, Qual Health Care 1995;4:80-90). This study addressed
surgical “never events” with respect to the ﬁnancial burdens they may place
on the health care system (malpractice claim payment) and characteristics
of providers involved with occurrence of surgical “never events.”The authors
used the National Practitioner Databank, a federal repository of medical
malpractice claims, to identify malpractice settlements and judgments of
surgical “never events.” Patient outcomes, payment amounts, and provider
characteristics were evaluated. The authors were able to identify 9744 paid
malpractice settlements and judgments for surgical “never events.” This
was for the period of 1990 to 2010. Malpractice payments for surgical “never
events” totaled $1.3 billion. Death occurred in 6.6% of patients, permanent
injury in 32.9%, and temporary injury in 59.2%. The authors estimate, based
on literature rates of surgical adverse events resulting in paid malpractice
claims, that 4082 surgical “never events” occur each year in theUnited States.
With respect to malpractice payments, increased malpractice claim payments
were associated with severe patient outcomes and claims involving a physician
with multiple malpractice reports. Of physicians named in a surgical “never
event” claim, 12.4% were later named in at least one future surgical “never
event” claim.
Comment: It has been suggested that medical errors occur when
there is a faulty system in a context of a weak culture for safety at an insti-
tutional level (Gosbee J, Qual Saf Health Care 2002;11:352-4). The
problem may be greater than alluded to in this study, because only 4% of
serious preventable adverse events result in complaints (Bismark MM et
al, Qual Saf Health Care 2006;15:17-22). It is the responsibility of hospitals
to support a culture of safety and the responsibility of physicians to support
this culture for the beneﬁt of their patients.
